Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients

Jann-Tay Wang, Wang-Huei Sheng, Chi-Tai Fang, Yee-Chun Chen, Jiun-Ling Wang, Chong-Jen Yu, Shan-Chwen Chang, Pan-Chyr Yang, Jann-Tay Wang, Wang-Huei Sheng, Chi-Tai Fang, Yee-Chun Chen, Jiun-Ling Wang, Chong-Jen Yu, Shan-Chwen Chang, Pan-Chyr Yang

Abstract

Clinical and laboratory data on severe acute respiratory syndrome (SARS), particularly on the temporal progression of abnormal laboratory findings, are limited. We conducted a prospective study on the clinical, radiologic, and hematologic findings of SARS patients with pneumonia, who were admitted to National Taiwan University Hospital from March 8 to June 15, 2003. Fever was the most frequent initial symptom, followed by cough, myalgia, dyspnea, and diarrhea. Twenty-four patients had various underlying diseases. Most patients had elevated C-reactive protein (CRP) levels and lymphopenia. Other common abnormal laboratory findings included leukopenia, thrombocytopenia, and elevated levels of aminotransferase, lactate dehydrogenase, and creatine kinase. These clinical and laboratory findings were exacerbated in most patients during the second week of disease. The overall case-fatality rate was 19.7%. By multivariate analysis, underlying disease and initial CRP level were predictive of death.

Figures

Figure
Figure
The time relationships between the time points of defervescence, initiation of steroid, and when chest radiographic finding as well as various laboratory parameters became most severe. Mean and standard deviation (days) are presented. CXR, chest radiography; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; AST, aspartate aminotransferase; CRP, C-reactive protein; CK, creatine kinase.

References

    1. World Health Organization. SARS epidemiology to date [monograph on the Internet]. 2003. [cited April 11, 2003]. Available from:
    1. World Health Organization Multicentre Collaborative Network for Severe Acute Respiratory Syndrome (SARS) Diagnosis. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet. 2003;361:1730–3. 10.1016/S0140-6736(03)13376-4
    1. World Health Organization. Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS) [monograph on the Internet]. [cited July 11, 2003]. Available from:
    1. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986–94. 10.1056/NEJMoa030685
    1. Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLM, et al. Clinical progression and viral load in a community-outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767–72. 10.1016/S0140-6736(03)13412-5
    1. So LKY, Lau ACW, Yan LYC, Cheung TMT, Poon E, Yung RWH, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet. 2003;361:1615–7. 10.1016/S0140-6736(03)13265-5
    1. World Health Organization. Severe acute respiratory syndrome (SARS): multi-country outbreak updated 34 [monograph on the Internet]. [cited May 5, 2003]. Available from:
    1. Moss M, Ingram RH Jr. Acute respiratory distress syndrome. In: Braunwald E, Fauci AS, Kasper DL, Hauser ST, Longo DI, Jameson JL, editors. Harrison’s principles of internal medicine. 15th ed. Washington: McGraw-Hill Medical Publishing Division; 2001. p. 1523–6.
    1. Centers for Disease Control and Prevention. International SARS case report form [monograph on the Internet]. [cited Mar 27, 2003]. Available from:
    1. Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia. Am J Med. 1980;68:344–55. 10.1016/0002-9343(80)90102-3
    1. Centers for Disease Control and Prevention. Severe acute respiratory syndrome—Taiwan, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:461–4.
    1. Cheung CY, Poon LL, Lau AS, Luk W, Lau YC, Shortridge KF, et al. Induction of postinflammatory cytokines in human macrophages by influenza A (H5N1) virus: a mechanism for the unusual severity of human disease? Lancet. 2002;360:1831–7. 10.1016/S0140-6736(02)11772-7
    1. Hooton TM, Haley RW, Culver DH, White JW, Morgan WM, Carroll RJ. The joint associations of multiple risk factors with the occurrence of nosocomial infection. Am J Med. 1981;70:960–70. 10.1016/0002-9343(81)90562-3
    1. Hsueh PR, Chen PJ, Hsiao CH, Yeh SH, Cheng WC, Wang JL, et al. Patient data, early SARS epidemic, Taiwan. Emerg Infect Dis. 2004;10. In press.
    1. Freeman B, Rathore MH, Salman E, Joyce MJ, Pitel P. Intravenously administered immune globulin for the treatment of infection-associated hemophagocytotic syndrome. J Pediatr. 1993;123:479–81. 10.1016/S0022-3476(05)81761-5
    1. Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. [erratum JAMA 2003;290:334]. JAMA. 2003;289:2801–9. 10.1001/jama.289.21.JOC30885
    1. Tillet WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1941;73:173–82.
    1. Johnson HL, Chiou CCC, Cho CT. Applications of acute phase reactants in infectious diseases. J Microbiol Immunol Infect. 1999;32:73–82.
    1. Lloyd-Jones DM, Levy D, Brezis M, Evans MK, Zonderman AB, Johnson WR, et al. C-reactive protein in the prediction of cardiovascular events. N Engl J Med. 2003;348:1059–61. 10.1056/NEJM200303133481115
    1. Singh U, Scheld WM. Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis. 1996;22:642–9.
    1. Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine. 1982;61:141–52. 10.1097/00005792-198205000-00002
    1. Wang JL, Wang JT, Yu CJ, Chen YC, Hsueh PR, Hsiao CH, et al. Rhabdomyolysis associated with probable SARS. Am J Med. 2003;115:421–2. 10.1016/S0002-9343(03)00448-0
    1. Berger JR, Sabet A. Infectious myelopathies. Semin Neurol. 2002;22:133–42. 10.1055/s-2002-36536
    1. McEvoy GK. AHFS Drug Information 2003. Bethesda: American Society of Health-System Pharmacists; 2003.
    1. Hund EF, Fogel W, Krieger D, DeGeorgia M, Hacke W. Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med. 1996;24:1328–33. 10.1097/00003246-199608000-00010
    1. National Taiwan University Hospital. Nosocomial infection surveillance, 2001. Taipei: National Taiwan University Hospital; 2002.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe